Efficacy of an experimental azithromycin cream for prophylaxis of tick-transmitted lyme disease spirochete infection in a murine model

Antimicrob Agents Chemother. 2014;58(1):348-51. doi: 10.1128/AAC.01932-13. Epub 2013 Oct 28.

Abstract

As an alternative to oral prophylaxis for the prevention of tick transmission of Borrelia burgdorferi, we tested antibiotic cream prophylactic formulations in a murine model of spirochete infection. A 4% preparation of doxycycline cream afforded no protection, but a single application of 4% azithromycin cream was 100% protective when applied directly to the tick bite site at the time of tick removal. Indeed, the azithromycin cream was 100% effective when applied at up to 3 days after tick removal and protected 74% of mice exposed to tick bite when applied at up to 2 weeks after tick removal. Azithromycin cream was also protective when applied at a site distal to the tick bite site, suggesting that it was having a systemic effect in addition to a local transdermal effect. Mice that were protected from tick-transmitted infection did not seroconvert and did not infect larval ticks on xenodiagnosis. Azithromycin cream formulations appear to hold promise for Lyme disease prophylaxis.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Azithromycin / therapeutic use*
  • Borrelia burgdorferi / drug effects*
  • Borrelia burgdorferi / pathogenicity*
  • Doxycycline / therapeutic use
  • Female
  • Lyme Disease / drug therapy*
  • Lyme Disease / microbiology*
  • Lyme Disease / transmission
  • Mice
  • Ticks / microbiology*

Substances

  • Anti-Bacterial Agents
  • Azithromycin
  • Doxycycline